Factors determining the efficacy of nuclear delivery of antisense oligonucleotides by gold nanoparticles

Bioconjugate Chemistry

Volumn 19, Issue 5, 2008, Pages 1009-1016

  Liu, Yanli ^a   Franzen, Stefan ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BODY FLUIDS; CELL MEMBRANES; CYTOLOGY; GENES; GOLD NANOPARTICLES; OLIGONUCLEOTIDES; PEPTIDES;

ANTISENSE OLIGONUCLEOTIDES; BOVINE SERUM ALBUMINS; CELL TARGETING; CONTROL EXPERIMENTS; DELIVERY VECTOR; GENE SPLICING; LIPOFECTAMINE; NUCLEAR DELIVERY; TARGET SEQUENCES; TARGETING PEPTIDES;

LIPOSOMES;

ADENOVIRUS VECTOR; ANTISENSE OLIGONUCLEOTIDE; BIOTIN; BOVINE SERUM ALBUMIN; GOLD; HYBRID PROTEIN; LIPOFECTAMINE; MESSENGER RNA; NANOPARTICLE; STREPTAVIDIN; THIOL;

ARTICLE; CELL MEMBRANE PERMEABILITY; CELL NUCLEUS; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG STABILITY; DRUG SYNTHESIS; ENDOCYTOSIS; HUMAN; HUMAN CELL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RNA SPLICING; SPLICEOSOME;

BOVINAE;

EID: 44349177463     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc700421u     Document Type: Article

References (52)

1. Hughes, J. A., Aronsohn, A. I., Avrutskaya, A. V., and Juliano, R. L. (1996) Evaluation of adjuvants that enhance the effectiveness of antisense oligodeoxynucleotides. Pharm. Res. 13, 404-410.
2. Boussif, O., Lezoualch, F., Zanta, M. A., Mergny, M. D., Scherman, D., Demeneix, B., and Behr, J. P. (1995) A versatile vector for gene and oligonucleotide transfer into cells in culture and in-vivo - polyethylenimine. Proc. Natl. Acad. Sci. U.S.A. 92, 7297-7301.
3. Bennett, C. F., Chiang, M. Y., Chan, H. D., Shoemaker, J. E. E., and Mirabelli, C. K. (1992) Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol. Pharm. 41, 1023-1033.
4. Curiel, D. T., Agarwal, S., Wagner, E., and Cotten, M. (1991) Adenovirus enhancement of transferrin polylysine-mediated gene delivery. Proc. Natl. Acad. Sci. U.S.A. 88, 8850-8854.
5. Rosenfeld, M. A., Siegfried, W., Yoshimura, K., Yoneyama, K., Fukayama, M., Stier, L. E., Paakko, P. K., Gilardi, P., Stratfordperricaudet, L. D., Perricaudet, M., Jallat, S., Pavirani, A., Lecocq, J. P., and Crystal, R. G. (1991) Adenovirus-mediated transfer of a recombinant α-L- antitrypsin gene to the lung epithelium in vivo. Science 252, 431-434.
6. Liu, Y. L., Shipton, M. K., Ryan, J., Kaufman, E. D., Franzen, S., and Feldheim, D. L. (2007) Synthesis, stability, and cellular internalization of gold nanoparticles containing mixed peptide-poly(ethylene glycol) monolayers. Anal. Chem. 79, 2221-2229.
7. Agbasi-Porter, C., Ryman-Rasmussen, J., Franzen, S., and Feldheim, D. (2006) Transcription inhibition using oligonucleotide-modified gold nanoparticles. Bioconjugate Chem. 17, 1178-1183.
8. Pena, S. R. N., Raina, S., Goodrich, G. P., Fedoroff, N. V., and Keating, C. D. (2002) Hybridization and enzymatic extension of Au nanoparticle-bound oligonucleotides. J. Am. Chem. Soc. 124, 7314-7323.
9. Rosi, N. L., Giljohann, D. A., Thaxton, C. S., Lytton-Jean, A. K. R., Han, M. S., and Mirkin, C. A. (2006) Oligonucleotide-modified gold nanoparticles for intracellular gene regulation. Science 312, 1027-1030.
10. Kogan, M. J., Olmedo, I., Hosta, L., Guerrero, A. R., Cruz, L. J., and Albericio, F. (2007) Peptides and metallic nanoparticles for biomedical applications. Nanomedicine 2, 287-306.
11. Oyelere, A. K., Chen, P. C., Huang, X. H., El-Sayed, I. H., and El-Sayed, M. A. (2007) Peptide-conjugated gold nanorods for nuclear targeting. Bioconjugate Chem. 18, 1490-1497.
12. Fortina, P., Kricka, L. J., Graves, D. J., Park, J., Hyslop, T., Tam, F., Halas, N., Surrey, S., and Waldman, S. A. (2007) Applications of nanoparticles to diagnostics and therapeutics in colorectal cancer. Trends Biotechnol. 25, 145-152.
13. Xie, H., Tkachenko, A. G., Glomm, W. R., Ryan, J. A., Brennaman, M. K., Papanikolas, J. M., Franzen, S., and Feldheim, D. L. (2003) Critical flocculation concentrations, binding isotherms, and ligand exchange properties of peptide-modified gold nanoparticles studied by UV-visible, fluorescence, and time-correlated single photon counting spectroscopies. Anal. Chem. 75, 5797-5805.
14. Kaufman, E. D., Belyea, J., Johnson, M. C., Nicholson, Z. M., Ricks, J. L., Shah, P. K., Bayless, M., Pettersson, T., Feldoto, Z., Blomberg, E., Claesson, P., and Franzen, S. (2007) Probing protein adsorption onto mercaptoundecanoic acid stabilized gold nanoparticles and surfaces by quartz crystal microbalance and zeta-potential measurements. Langmuir 23, 6053-6062.
15. Demers, L. M., Mirkin, C. A., Mucic, R. C., Reynolds, R. A., Letsinger, R. L., Elghanian, R., and Viswanadham, G. (2000) A fluorescence-based method for determining the surface coverage and hybridization efficiency of thiol-capped oligonucleotides bound to gold thin films and nanoparticles. Anal. Chem. 72, 5535-5541.
16. Murphy, D., Redmond, G., de la Torre, B. G., and Eritja, R. (2004) Hybridization and melting Behavior of peptide nucleic acid (PNA) oligonucleotide chimeras conjugated to gold nanoparticles. Helv. Chim. Acta 87, 2727-2734.
17. Nitin, N., Javier, D. J., and Richards-Kortum, R. (2007) Oligonucleotide-coated metallic nanoparticles as a flexible platform for molecular Imaging agents. Bioconjugate Chem. 18, 2090-2096.
18. Levy, R., Thanh, N. T. K., Doty, R. C., Hussain, I., Nichols, R. J., Schiffrin, D. J., Brust, M., and Fernig, D. G. (2004) Rational and combinatorial design of peptide capping ligands for gold nanoparticles. J. Am. Chem. Soc. 126, 10076-10084.
19. Tkachenko, A. G., Xie, H., Coleman, D., Glomm, W., Ryan, J., Anderson, M. F., Franzen, S., and Feldheim, D. L. (2003) Multifunctional gold nanoparticle-peptide complexes for nuclear targeting. J. Am. Chem. Soc. 125, 4700-4701.
20. Tkachenko, A. G., Xie, H., Liu, Y. L., Coleman, D., Ryan, J., Glomm, W. R., Shipton, M. K., Franzen, S., and Feldheim, D. L. (2004) Cellular trajectories of peptide-modified gold particle complexes: Comparison of nuclear localization signals and peptide transduction domains. Bioconjugate Chem. 15, 482-490.
21. Weber, P. C., Ohlendorf, D. H., Wendoloski, J. J., and Salemme, F. R. (1989) Structural origins of high-affinity biotin binding to streptavidin. Science 243, 85-88.
22. Moritz, S., Colin, M., Keller, M., Klonjkowski, B., Capeau, J., Coutelle, C., Chroboczek, J., and Brahimi-Horn, M. C. (2003) Gene transfer by adenovirus-mimetic peptides in the presence of a cationic lipid and/or adenovirus. Analysis of the contribution of the viral and nonviral components. Arch. Virol. 148, 1-18.
23. Cusack, S. (2005) Adenovirus complex structures. Curr. Opin. Struct. Biol. 15, 237-243.
24. Okada, Y., Okada, N., Mizuguchi, H., Hayakawa, T., Nakagawa, S., and Mayumi, T. (2005) Transcriptional targeting of RGD fiber-mutant adenovirus vectors can improve the safety of suicide gene therapy for murine melanoma. Cancer Gene Ther. 12, 608-616.
25. Eto, Y., Gao, J. Q., Sekiguchi, F., Kurachi, S., Katayama, K., Maeda, M., Kawasaki, K., Mizuguchi, H., Hayakawa, T., Tsutsumi, Y., Mayumi, T., and Nakagawa, S. (2005) PEGylated adenovirus vectors containing RGD peptides on the tip of PEG show high transduction efficiency and antibody evasion ability. J. Gene Med. 7, 604-612.
26. Smith, R. A., and Giorgio, T. D. (2004) Quantitation and kinetics of CD51 surface receptor expression: Implications for targeted delivery. Ann. Biomed. Eng. 32, 635-644.
27. Lanford, R. E., Kanda, P., and Kennedy, R. C. (1986) Induction of nuclear transport with a synthetic peptide homologous to the Sv40 T-antigen transport signal. Cell 46, 575-582.
28. Zanta, M. A., Belguise-Valladier, P., and Behr, J. P. (1999) Gene delivery: A single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. Proc. Natl. Acad. Sci. U.S.A. 96, 91-96.
29. Sazani, P., and Kole, R. (2003) Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing. J. Clin. Invest. 112, 481-486.
30. Kole, R., and Sazani, P. (2001) Antisense effects in the cell nucleus: Modification of splicing. Curr. Opin. Mol. Ther. 3, 229-234.
31. Sierakowska, H., Gorman, L., Kang, S. H., and Kole, R. (2000) Antisense oligonucleotides and RNAs as modulators of pre-mRNA splicing. Antisense Technol. Part A 2000 506-521.
32. Chan, J. H. P., Lim, S. H., and Wong, W. S. F. (2006) Antisense oligonucleotides: From design to therapeutic application. Clin. Exp. Pharmacol. Physiol. 33, 533-540.
33. Yu, A. M. (2007) Small interfering RNA in drug metabolism and transport. Curr. Drug Metabol. 8, 700-708.
34. Goodchild, J. (2004) Oligonucleotide therapeutics: 25 years agrowing. Curr. Opin. Mol. Ther. 6, 120-128.
35. Crooke, S. T. (2004) Progress in antisense technology. Ann. Rev. Med. 55, 61-95.
36. Gebski, B. L., Mann, C. J., Fletcher, S., and Wilton, S. D. (2003) Morpholino antisense oligonucleotides for inducing exon skipping. J. Gene Med. 5, S10-S10.
37. Braasch, D. A., and Corey, D. R. (2002) Novel antisense and peptide nucleic acid strategies for controlling gene expression. Biochemistry 41, 4503-4510.
38. Sazani, P., Kang, S. H., Maier, M. A., Wei, C. F., Dillman, J., Summerton, J., Manoharan, M., and Kole, R. (2001) Nuclear antisense effects of neutral, anionic and cationic oligonucleotide analogs. Nucleic Acids Res. 29, 3965-3974.
39. Kang, S. H., Cho, M. J., and Kole, R. (1998) Up-regulation of luciferase gene expression with antisense oligonucleotides: Implications and applications in functional assay developments. Biochemistry 37, 6235-6239.
40. Pante, N., and Kann, M. (2000) The functional diameter of the nuclear pore complex has been severely underestimated. Mol. Biol. Cell 11, 151A-152A.
41. Ludtke, J. J., Zhang, G. F., Sebestyen, M. G., and Wolff, J. A. (1999) A nuclear localization signal can enhance both the nuclear transport and expression of 1 kb DNA. J. Cell Sci. 112, 2033-2041.
42. Zhang, F., Andreassen, P., Fender, P., Geissler, E., Hernandez, J. F., and Chroboczek, J. (1999) A transfecting peptide derived from adenovirus fiber protein. Gene Ther. 6, 171-181.
43. Rozenzhak, S. M., Kadakia, M. P., Caserta, T. M., Westbrook, T. R., Stone, M. O., and Naik, R. R. (2005) Cellular internalization and targeting of semiconductor quantum dots. Chem. Commun. 2217-2219.
44. Richard, J. P., Melikov, K., Vives, E., Ramos, C., Verbeure, B., Gait, M. J., Chernomordik, L. V., and Lebleu, B. (2003) Cell-penetrating peptides - A reevaluation of the mechanism of cellular uptake. J. Biol. Chem. 278, 585-590.
45. Lundberg, M., Wikstrom, S., and Johansson, M. (2003) Cell surface adherence and endocytosis of protein transduction domains. Mol. Ther. 8, 143-150.
46. Gestwicki, J. E., Cairo, C. W., Strong, L. E., Oetjen, K. A., and Kiessling, L. L. (2002) Influencing receptor-ligand binding mechanisms with multivalent ligand architecture. J. Am. Chem. Soc. 124, 14922-14933.
47. Warnement, M. R., Faley, S. L., Wikswo, J. P., and Rosenthal, S. J. (2006) Quantum dot probes for monitoring dynamic cellular response: Reporters of T cell activation. IEEE Trans. Nanobiosci. 5, 268-272.
48. Loo, L., Guenther, R. H., Basnayake, V. R., Lommel, S. A., and Franzen, S. (2006) Controlled encapsidation of gold nanoparticles by a viral protein shell. J. Am. Chem. Soc. 128, 4502-4503.
49. Loo, L., Guenther, R. H., Lommel, S. A., and Franzen, S. (2007) Encapsidation of nanoparticies by Red Clover Necrotic Mosaic Virus. J. Am. Chem. Soc. 129, 11111-11117.
50. Loo, L., Guenther, R. H., Lommel, S. A., and Franzen, S. (2008) Infusion of dye molecules into Red clover necrotic mosaic virus. Chem. Commun. 88-90.
51. Feldherr, C. M., and Akin, D. (1999) Signal-mediated nuclear transport in the amoeba. J. Cell Sci. 112, 2043-2048.
52. Colin, M., Maurice, M., Trugnan, G., Kornprobst, M., Harbottle, R. P., Knight, A., Cooper, R. G., Miller, A. D., Capeau, J., Coutelle, C., and Brahimi-Horn, M. C. (2000) Cell delivery, intracellular trafficking and expression of an integrin-mediated gene transfer vector in tracheal epithelial cells. Gene Ther. 7, 139-152.